🇺🇸 Minocyline in United States

17 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 28 March 2025 – 28 March 2026
• Total reports: 17

Most-reported reactions

1. Arthritis — 3 reports (17.65%)
2. Condition Aggravated — 2 reports (11.76%)
3. Infection — 2 reports (11.76%)
4. Lupus-Like Syndrome — 2 reports (11.76%)
5. Pain — 2 reports (11.76%)
6. Weight Increased — 2 reports (11.76%)
7. Acarodermatitis — 1 report (5.88%)
8. Acute Respiratory Distress Syndrome — 1 report (5.88%)
9. Anorexia — 1 report (5.88%)
10. Arthralgia — 1 report (5.88%)

Source database →

Frequently asked questions

Is Minocyline approved in United States?

Minocyline does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Minocyline in United States?

German Parkinson Study Group (GPS) is the originator. The local marketing authorisation holder may differ — check the official source linked above.